Mallinckrodt Actively Evaluating Capital Needs In Light Of Its Obligations Under Its Opioid Settlement And Its Long-Term Debt; On June 15, Co, Opioid Master Disbursement Trust II Entered Amendment No. 1 To Certain Opioid Deferred Cash Payments Agreement
Portfolio Pulse from Benzinga Newsdesk
Mallinckrodt is actively evaluating its capital needs due to obligations under its opioid settlement and long-term debt. The company and Opioid Master Disbursement Trust II entered Amendment No. 1 to a certain opioid deferred cash payments agreement on June 15.
June 16, 2023 | 4:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mallinckrodt is assessing its capital needs due to its opioid settlement obligations and long-term debt, which may impact its financial stability.
Mallinckrodt's ongoing evaluation of its capital needs due to its opioid settlement obligations and long-term debt indicates potential financial instability. This may negatively impact the company's stock price in the short term as investors may perceive increased risk.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100